Program information, agendas and faculty
details are subject to change. Please check back for the most up-to-date
information.
The course aims to provide a clinical-based overview on the scientific basis for the use of biologics to treat orthopaedic sports medicine pathology. The various treatment options available, including growth factors, platelet rich plasma, and stem cells will be presented, and the basic science rationale behind their use clarified. Their clinical use will be presented, the regulatory issues related to their use, and the evidence on their effectiveness and efficacy will be discussed.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Orthopaedic Surgeons and the International Society of Arthroscopy, Knee Surgery and Sports Medicine. The American Academy of Orthopaedic Surgeons is accredited by the ACCME to provide continuing medical education for physicians.
The American Academy of Orthopaedic Surgeons designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits™.
| |
|
13:00 - 13:05
|
|
Introduction
Welcome: Overview and Goals of this Precourse for the Use of Biologics to Treat Sports Medicine Pathology
|
|
|
|
|
|
Chair:
Robert F. LaPrade, MD, PhD UNITED STATES
|
|
|
| |
| |
|
13:05 - 13:15
|
|
Bone Marrow-Derived Stem Cells: Where Are We Now?
|
|
|
|
|
|
Constance R. Chu, MD UNITED STATES
|
|
|
| |
|
13:15 - 13:25
|
|
Muscle Derived Stem Cells: Where Are We Now?
|
|
|
|
|
|
Johnny Huard, PhD UNITED STATES
|
|
|
| |
|
13:25 - 13:35
|
|
Adipose-Derived Stem Cells: Where Are We Now?
|
|
|
|
|
|
Iain Robert Murray, MD, PhD UNITED KINGDOM
|
|
 |
| |
|
13:35 - 13:45
|
|
Tendon-Derived Stem Cells: Where Are We Now?
|
|
|
|
|
|
Nicola Maffulli, MD, PhD, MS, FRCS(Orth) UNITED KINGDOM
|
|
|
| |
|
13:45 - 13:55
|
|
Tendon Stem Cells and Aging: What Are the implications?
|
|
|
|
|
|
Umile Giuseppe Longo, MD, MSc, PhD, Prof. ITALY
|
|
|
| |
|
13:55 - 14:15
|
|
Panel Discussion, Questions & Answers
|
|
|
|
|
|
Constance R. Chu, MD UNITED STATES
|
|
|
|
|
|
Johnny Huard, PhD UNITED STATES
|
|
|
|
|
|
Umile Giuseppe Longo, MD, MSc, PhD, Prof. ITALY
|
|
|
|
|
|
Iain Robert Murray, MD, PhD UNITED KINGDOM
|
|
|
| |
| |
|
14:15 - 14:27
|
|
Use of Biologics for Improving Healing for Tendinopathy
|
|
|
|
|
|
Laurie Goodrich, DVM, PhD UNITED STATES
|
|
|
| |
|
14:27 - 14:39
|
|
Use of ACL-Derived Stem Cells For Ligament Repair or Reconstruction
|
|
|
|
|
|
Norimasa Nakamura, MD, PhD JAPAN
|
|
|
| |
|
14:39 - 14:51
|
|
Updates on Achieving ACL Healing After Repair
|
|
|
|
|
|
Jorge Chahla, MD, PhD UNITED STATES
|
|
|
| |
|
14:51 - 15:10
|
|
Panel Discussion, Questions & Answers
|
|
|
|
|
|
Jorge Chahla, MD, PhD UNITED STATES
|
|
|
|
|
|
Norimasa Nakamura, MD, PhD JAPAN
|
|
|
| |
| |
| |
|
15:25 - 15:35
|
|
The Use of Biologic Factors to Enhance Rotator Cuff Healing
|
|
|
|
|
|
Adam W. Anz, MD UNITED STATES
|
|
|
| |
|
15:35 - 15:45
|
|
Mesenchymal Stem Cells for Augmenting Rotator Cuff Repair
|
|
|
|
|
|
Philippe Hernigou FRANCE
|
|
|
| |
|
15:45 - 16:00
|
|
Growth Factors and PRP for Rotator Cuff Repair
|
|
|
|
|
|
Nicola Maffulli, MD, PhD, MS, FRCS(Orth) UNITED KINGDOM
|
|
|
| |
| |
|
16:00 - 16:10
|
|
PRP for Treating Ligament Tears
|
|
|
|
|
|
Robert F. LaPrade, MD, PhD UNITED STATES
|
|
|
| |
|
16:10 - 16:20
|
|
PRP for Treating Tendinopathy
|
|
|
|
|
|
Lars Engebretsen, MD, PhD NORWAY
|
|
|
| |
|
16:20 - 16:30
|
|
PRP for Augmenting Microfracture
|
|
|
|
|
|
Elizaveta Kon, Prof., MD ITALY
|
|
|
| |
|
16:30 - 16:40
|
|
Updates on Regulatory Issues for Biologic Use
|
|
|
|
|
|
Andrew Geeslin, MD UNITED STATES
|
|
|
| |
|
16:40 - 17:00
|
|
Panel Discussion, Questions & Answers
|
|
|
|
|
|
Lars Engebretsen, MD, PhD NORWAY
|
|
|
|
|
|
Andrew Geeslin, MD UNITED STATES
|
|
|
|
|
|
Elizaveta Kon, Prof., MD ITALY
|
|
|
|
|
|
Robert F. LaPrade, MD, PhD UNITED STATES
|
|
|
| |